Published in Stroke on January 03, 2008
Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med (2011) 2.68
Off-label recombinant factor VIIa use and thrombosis in children: a multi-center cohort study. J Pediatr (2010) 1.15
Timing is everything in intracerebral hemorrhage. Stroke (2008) 0.75
Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2005) 9.58
The ABCs of measuring intracerebral hemorrhage volumes. Stroke (1996) 6.78
Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke (1997) 4.55
Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa. Neurology (2006) 2.27
Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke (2004) 1.60
Early presentation of hemispheric intracerebral hemorrhage: prediction of outcome and guidelines for treatment allocation. Neurology (1994) 1.52
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 12.92
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med (2004) 5.32
Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol (2012) 3.11
Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet (2009) 2.50
Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results. Stroke (2010) 2.29
Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology (2002) 2.18
Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Lancet Neurol (2011) 2.15
Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO). Stroke (2005) 2.12
Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann Neurol (2007) 2.05
Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project. Stroke (2002) 1.97
Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res (2010) 1.89
Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab (2009) 1.80
Anticoagulation after cardioembolic stroke: to bridge or not to bridge? Arch Neurol (2008) 1.79
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke (2007) 1.75
The IVH score: a novel tool for estimating intraventricular hemorrhage volume: clinical and research implications. Crit Care Med (2009) 1.73
Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke (2006) 1.70
Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST trial. J Neuroimaging (2004) 1.69
The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study. Stroke (2012) 1.68
Changes in spleen size in patients with acute ischemic stroke: a pilot observational study. Int J Stroke (2012) 1.66
Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol (2011) 1.64
LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis (2008) 1.62
Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial. Stroke (2002) 1.62
Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke (2007) 1.61
Inpatient rehabilitation centers and concern for increasing volume of ischemic stroke patients requiring rehabilitation. South Med J (2013) 1.60
Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke (2004) 1.59
Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic stroke. Arch Neurol (2008) 1.59
Accuracy of serial National Institutes of Health Stroke Scale scores to identify artery status in acute ischemic stroke. Circulation (2007) 1.58
Current concepts of hemostasis: implications for therapy. Anesthesiology (2004) 1.55
Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial. Ann Neurol (2009) 1.52
Yield and accuracy of urgent combined carotid/transcranial ultrasound testing in acute cerebral ischemia. Stroke (2004) 1.50
Sustained benefit of a community and professional intervention to increase acute stroke therapy. Arch Intern Med (2003) 1.48
What change in the National Institutes of Health Stroke Scale should define neurologic deterioration in acute ischemic stroke? J Stroke Cerebrovasc Dis (2012) 1.48
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
A prospective, multicenter pilot study to evaluate the feasibility and safety of using the CoolGard System and Icy catheter following cardiac arrest. Resuscitation (2004) 1.46
The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Ann Emerg Med (2005) 1.44
Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable. Stroke (2005) 1.42
A randomized, controlled trial to teach middle school children to recognize stroke and call 911: the kids identifying and defeating stroke project. Stroke (2007) 1.42
Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia. J Neurosci (2009) 1.41
Thrombolysis in stroke despite contraindications or warnings? Stroke (2013) 1.40
Can comprehensive stroke centers erase the 'weekend effect'? Cerebrovasc Dis (2008) 1.39
Feasibility of carotid artery stenting in patients with angiographic string sign. Catheter Cardiovasc Interv (2010) 1.39
Prevalence of atherosclerotic plaque in young and middle-aged asymptomatic individuals: the Bogalusa heart study. South Med J (2011) 1.39
Trimming the fat in acute ischemic stroke: an assessment of 24-h CT scans in tPA patients. Int J Stroke (2014) 1.39
Cell death in experimental intracerebral hemorrhage: the "black hole" model of hemorrhagic damage. Ann Neurol (2002) 1.39
Neuroprotective role of haptoglobin after intracerebral hemorrhage. J Neurosci (2009) 1.38
Constraint-induced movement therapy during early stroke rehabilitation. Neurorehabil Neural Repair (2006) 1.34
Argatroban tPA stroke study: study design and results in the first treated cohort. Arch Neurol (2006) 1.33
Angiosarcoma: clinical and molecular insights. Ann Surg (2010) 1.33
The spot sign in intracerebral hemorrhage: the importance of looking for contrast extravasation. Cerebrovasc Dis (2009) 1.30
A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres for acute ischemic stroke. Stroke (2008) 1.30
15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats. J Cereb Blood Flow Metab (2006) 1.26
IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways. Brain Res (2010) 1.24
Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. J Neurosci Res (2011) 1.24
Thrombolytic therapy for patients who wake-up with stroke. Stroke (2009) 1.23
Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion. J Neuroimaging (2002) 1.23
Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial. Stroke (2010) 1.22
Joint commission primary stroke centers utilize more rt-PA in the nationwide inpatient sample. J Am Heart Assoc (2013) 1.22
Intravenous TPA for very old stroke patients. Eur Neurol (2005) 1.21
Intracerebral hemorrhage in cocaine users. Stroke (2010) 1.20